Title
Selective activation of protein kinase C{small element of} in mitochondria is neuroprotective in vitro and reduces focal ischemic brain injury in mice
Date Issued
01 June 2013
Access level
open access
Resource Type
journal article
Author(s)
Sun X.
Budas G.R.
Xu L.
Mochly-Rosen D.
Giffard R.G.
Stanford University School of Medicine
Abstract
Activation of protein kinase C{small element of} (PKC{small element of}) confers protection against neuronal ischemia/reperfusion. Activation of PKC{small element of} leads to its translocation to multiple intracellular sites, so a mitochondria-selective PKC{small element of} activator was used to test the importance of mitochondrial activation to the neuroprotective effect of PKC{small element of}. PKC{small element of} can regulate key cytoprotective mitochondrial functions, including electron transport chain activity, reactive oxygen species (ROS) generation, mitochondrial permeability transition, and detoxification of reactive aldehydes. We tested the ability of mitochondria-selective activation of PKC{small element of} to protect primary brain cell cultures or mice subjected to ischemic stroke. Pretreatment with either general PKC{small element of} activator peptide, TAT-Ψ{small element of}RACK, or mitochondrial-selective PKC{small element of} activator, TAT-Ψ{small element of}HSP90, reduced cell death induced by simulated ischemia/reperfusion in neurons, astrocytes, and mixed neuronal cultures. The protective effects of both TAT-Ψ{small element of}RACK and TAT-Ψ{small element of}HSP90 were blocked by the PKC{small element of} antagonist {small element of}V1-2, indicating that protection requires PKC{small element of} interaction with its anchoring protein, TAT-{small element of}RACK. Further supporting a mitochondrial mechanism for PKC{small element of}, neuroprotection by TAT-Ψ{small element of}HSP90 was associated with a marked delay in mitochondrial membrane depolarization and significantly attenuated ROS generation during ischemia. Importantly, TAT-Ψ{small element of}HSP90 reduced infarct size and reduced neurological deficit in C57/BL6 mice subjected to middle cerebral artery occlusion and 24 hr of reperfusion. Thus selective activation of mitochondrial PKC{small element of} preserves mitochondrial function in vitro and improves outcome in vivo, suggesting potential therapeutic value clinically when brain ischemia is anticipated, including neurosurgery and cardiac surgery. © 2013 Wiley Periodicals, Inc.
Start page
799
End page
807
Volume
91
Issue
6
Language
English
OCDE Knowledge area
Neurociencias
Scopus EID
2-s2.0-84876480539
PubMed ID
Source
Journal of Neuroscience Research
ISSN of the container
03604012
Sponsor(s)
National Heart, Lung, and Blood Institute - R01HL052141
Sources of information: Directorio de Producción Científica Scopus